XML 23 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
Share data in Thousands, except Per Share data, unless otherwise specified
4 Months Ended 12 Months Ended
Dec. 31, 2012
Segment
Aug. 31, 2012
Aug. 31, 2011
Aug. 31, 2010
Cash and Cash Equivalents [Abstract]        
Maximum maturity period for investments considered as highly liquid investments 3 months      
Short-term Investments [Abstract]        
Short-term duration government fund $ 22,100,000 $ 15,300,000    
Prepaid Expenses and Other [Abstract]        
Period within which prepaid expenses consists primarily of advance payments to vendors will be expensed 1 year      
Debt Instrument [Line Items]        
Loan with HealthCare Royalty Partners Note payable consists of the Company's loan agreement with HealthCare Royalty Partners ("HC Royalty"), as lender, under which the Company agreed to borrow $50 million in two $25 million tranches. The Company received the first tranche in the amount of $25 millionin December 2012. The loan bears interest at an annual fixed rate of 10.75% of outstanding principal and includes a synthetic royalty component based on net product sales in a calendar year.      
Finite-Lived Intangible Assets [Line Items]        
Estimated useful life of intangible assets 20 years      
Fixed Assets [Abstract]        
Useful life of significant additions and improvements in fixed assets for capitalization greater than one      
Segment Information [Abstract]        
Number of operating segments 1      
Income taxes [Abstract]        
Accrued interest and penalties related to uncertain tax positions 0      
Advertising Expense [Abstract]        
Advertising expense 1,300,000 2,500,000    
Potentially dilutive securities [Abstract]        
Warrants to purchase common stock (in shares) 4,563 5,188 7,019  
Options to purchase common stock (in shares) 7,791 6,125 3,581  
Total potentially dilutive securities (in shares) 12,354 11,313 10,600  
Operating earnings per share basic and diluted (in dollars per share) $ (0.37) $ (0.80) $ (1.15) $ (0.85)
Out license [Member]
       
Finite-Lived Intangible Assets [Line Items]        
Estimated useful life of intangible assets 16 years      
IP license for RP103 and RP104 [Member]
       
Finite-Lived Intangible Assets [Line Items]        
Estimated useful life of intangible assets 20 years      
Loan Agreement with HC Royalty [Member]
       
Debt Instrument [Line Items]        
Total amount of loan 50,000,000      
Number of tranches in loan 2      
Amount of loan per tranche $ 25,000,000      
Annual fixed interest rate (in hundredths) 10.75%